Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advance Solid Tumors”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableLooking for participantsNCT01365169
What this trial is testing

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Who this might be right for
Malignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45 more
M.D. Anderson Cancer Center 590
Early research (Phase 1)Study completedNCT00423254
What this trial is testing

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Who this might be right for
OvarianMelanomaRenal+20 more
Mannkind Corporation 12
Early research (Phase 1)Study completedNCT00731263
What this trial is testing

Tor Kinase Inhibitor in Advanced Tumors

Who this might be right for
Solid Tumors
AstraZeneca 64
Early research (Phase 1)Ended earlyNCT01137552
What this trial is testing

Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Amgen 44
Early research (Phase 1)Temporarily pausedNCT07529535
What this trial is testing

A First-in-Human Study of ALK-N001 for Injection in Patients With Advanced Solid Tumors

Who this might be right for
Advance Solid Tumors
Zhejiang Anglikang Pharmaceutical Co., Ltd. 16
Early research (Phase 1)Study completedNCT02301117
What this trial is testing

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment

Who this might be right for
Advanced Solid Tumors
Taiho Oncology, Inc. 43
Early research (Phase 1)Ended earlyNCT05621525
What this trial is testing

Phase I Study of the BBP-398 in Patients With Advance Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced or Metastatic Non-small Cell Lung Cancer
LianBio LLC 7
Not applicableLooking for participantsNCT06795815
What this trial is testing

The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease

Who this might be right for
LeukemiaMultiple MielomaAdvanced Solid Tumors+3 more
Azienda USL Reggio Emilia - IRCCS 75
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Testing effectiveness (Phase 2)Looking for participantsNCT06249048
What this trial is testing

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Who this might be right for
Advanced Solid Tumor
Strand Therapeutics Inc. 108
Not applicableStudy completedNCT04889144
What this trial is testing

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
Fred Hutchinson Cancer Center 27
Not applicableStudy completedNCT01817686
What this trial is testing

Study of Default Options in Advance Directives

Who this might be right for
COPDSevere or Very Severe Airflow Obstruction and/or Receiving or Eligible to Receive Long-term Oxygen TherapyIdiopathic Pulmonary Fibrosis+5 more
Corporal Michael J. Crescenz VA Medical Center 62
Early research (Phase 1)Looking for participantsNCT07229313
What this trial is testing

KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advance Solid Tumors
Kivu Bioscience Inc. 76
Early research (Phase 1)Study completedNCT01120288
What this trial is testing

A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases

Who this might be right for
NeoplasmsLiver Metastases
National Cancer Institute (NCI) 10
Early research (Phase 1)Study completedNCT00503204
What this trial is testing

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Who this might be right for
Recurrent GlioblastomaBrain Tumor
AstraZeneca 20
Early research (Phase 1)Study completedNCT01213381
What this trial is testing

Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors

Who this might be right for
Advance Solid Tumors
Sanofi 18
Testing effectiveness (Phase 2)Study completedNCT03035591
What this trial is testing

ODM-207 in Patients With Advance Solid Tumours

Who this might be right for
Solid Tumors
Orion Corporation, Orion Pharma 36
Early research (Phase 1)Study completedNCT04850755
What this trial is testing

A Phase I Dose Escalation Study of Selinexor Plus Nivolumab and Ipilimumab in Advanced/Metastatic Solid Malignancies

Who this might be right for
Advance Solid MalignanciesMetastatic Solid Malignancies
National University Hospital, Singapore 11
Testing effectiveness (Phase 2)Looking for participantsNCT04775485
What this trial is testing

Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors

Who this might be right for
Low-grade GliomaAdvanced Solid Tumor
Day One Biopharmaceuticals, Inc. 141
Early research (Phase 1)Study completedNCT00426140
What this trial is testing

Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.

Who this might be right for
Advanced MalignanciesSolid Tumors
Novartis Pharmaceuticals 5
Load More Results